Literature DB >> 28189372

Epidemiology, environmental risk factors and genetics of Parkinson's disease.

Anna Delamarre1, Wassilios G Meissner2.   

Abstract

Parkinson's disease (PD) is a frequent neurodegenerative disease with a premotor phase that lasts several years. Risk factors that have been linked to PD are tobacco, caffeine, black tea, pesticides and calcium channel blockers. Some risk factors may be due to inverse causality (e.g. changes in personality during the premotor phase). The genetics of PD are complex with a contribution of Mendelian (e.g. SNCA, LRRK2, Parkin, Pink1,…) and non-Mendelian factors (e.g. single nucleotide polymorphisms). Glucocerebrosidase gene mutations (Gaucher disease) are currently the strongest genetic risk factor for PD. Studying risk factors will help to better understand the pathogenesis of PD.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28189372     DOI: 10.1016/j.lpm.2017.01.001

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  45 in total

Review 1.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

2.  Release parameters during progressive degeneration of dopamine neurons in a mouse model reveal earlier impairment of spontaneous than forced behaviors.

Authors:  Yuan-Hao Chen; Tsung-Hsun Hsieh; Tung-Tai Kuo; Jen-Hsin Kao; Kuo-Hsing Ma; Eagle Yi-Kung Huang; Yu-Ching Chou; Lars Olson; Barry J Hoffer
Journal:  J Neurochem       Date:  2019-05-09       Impact factor: 5.372

3.  Associations of Lower Caffeine Intake and Plasma Urate Levels with Idiopathic Parkinson's Disease in the Harvard Biomarkers Study.

Authors:  Rachit Bakshi; Eric A Macklin; Albert Y Hung; Michael T Hayes; Bradley T Hyman; Anne-Marie Wills; Stephen N Gomperts; John H Growdon; Alberto Ascherio; Clemens R Scherzer; Michael A Schwarzschild
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

4.  Familial Parkinson's Disease-Associated L166P Mutant DJ-1 is Cleaved by Mitochondrial Serine Protease Omi/HtrA2.

Authors:  Kai Fu; Yanfei Wang; Dongkai Guo; Guanghui Wang; Haigang Ren
Journal:  Neurosci Bull       Date:  2017-11-24       Impact factor: 5.203

Review 5.  Parkinson's Disease: A Multisystem Disorder.

Authors:  Helena Nunes Costa; Ana Raquel Esteves; Nuno Empadinhas; Sandra Morais Cardoso
Journal:  Neurosci Bull       Date:  2022-08-22       Impact factor: 5.271

Review 6.  Role of Nrf2 in Parkinson's Disease: Toward New Perspectives.

Authors:  Xin-Xing Yang; Rong Yang; Feng Zhang
Journal:  Front Pharmacol       Date:  2022-06-24       Impact factor: 5.988

Review 7.  The Renin-Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene.

Authors:  Tamara Kobiec; Matilde Otero-Losada; Guenson Chevalier; Lucas Udovin; Sofía Bordet; Camila Menéndez-Maissonave; Francisco Capani; Santiago Pérez-Lloret
Journal:  Front Synaptic Neurosci       Date:  2021-04-22

8.  Posttraumatic parkinsonism would increase the mortality risk in elderly patients with traumatic brain injury.

Authors:  Dorji Harnod; Yu-Shu Yen; Cheng-Li Lin; Tomor Harnod; Chia-Hung Kao
Journal:  Ann Transl Med       Date:  2019-12

9.  Case-control study of hypertension and Parkinson's disease.

Authors:  Yuen-Fann Ng; Ebonne Ng; Ee-Wei Lim; Kumar M Prakash; Louis C S Tan; Eng-King Tan
Journal:  NPJ Parkinsons Dis       Date:  2021-07-21

10.  In vitro inhibition of glutathione-S-transferase by dopamine and its metabolites, 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylacetic acid.

Authors:  Rachel A Crawford; Kate R Bowman; Brianna S Cagle; Jonathan A Doorn
Journal:  Neurotoxicology       Date:  2021-07-24       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.